Amanda Jagolino
University of Texas Health Science Center at Houston
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Amanda Jagolino.
Stroke | 2017
Tzu Ching Wu; Stephanie Parker; Amanda Jagolino; Jose Miguel Yamal; Ritvij Bowry; Abraham Thomas; Amy Yu; James C. Grotta
Background and Purpose— The BEST-MSU study (Benefits of Stroke Treatment Delivered Using a Mobile Stroke Unit) is a comparative effectiveness trial in patients randomized to mobile stroke unit or standard management. A substudy tested interrater agreement for tissue-type plasminogen activator eligibility between a telemedicine vascular neurologist and onboard vascular neurologist. Methods— On scene, both the telemedicine vascular neurologist and onboard vascular neurologist independently evaluated the patient, documenting their tissue-type plasminogen activator treatment decision, National Institutes of Health Stroke Scale score, and computed tomographic interpretation. Agreement was determined using Cohen &kgr; statistic. Telemedicine-related technical failures that impeded remote assessment were recorded. Results— Simultaneous and independent telemedicine vascular neurologist and onboard vascular neurologist assessment was attempted in 174 patients. In 4 patients (2%), the telemedicine vascular neurologist could not make a decision because of technical problems. The telemedicine vascular neurologist agreed with the onboard vascular neurologist on 88% of evaluations (&kgr;=0.73). Conclusions— Remote telemedicine vascular neurologist assessment is reliable and accurate, supporting either telemedicine vascular neurologist or onboard vascular neurologist assessment on our mobile stroke unit. Clinical Trial Registration— URL: http://www.clinicaltrials.gov. Unique identifier: NCT02190500.
Neurology | 2016
Amanda Jagolino; Judy Jia; Kasey Gildersleeve; Christy Ankrom; Chunyan Cai; Mohammad H. Rahbar; Sean I. Savitz; Tzu Ching Wu
During the 20 years since US Food and Drug Administration approval of IV tissue plasminogen activator for acute ischemic stroke, vascular neurology consultation via telemedicine has contributed to an increased frequency of IV tissue plasminogen activator administration and broadened geographic access to the drug. Nevertheless, a growing demand for acute stroke coverage persists, with the greatest disparity found in rural communities underserved by neurologists. To provide efficient and consistent acute care, formal training in telemedicine during neurovascular fellowship is warranted. Herein, we describe our experiences incorporating telestroke into the vascular neurology fellowship curriculum and propose recommendations on integrating formal telemedicine training into the Accreditation Council for Graduate Medical Education vascular neurology fellowship.
Internal Medicine Review | 2017
Ketevan Berekashvili; Amanda Jagolino; Christy Ankrom; James C. Grotta
Stroke | 2016
Amanda Jagolino; Chunyan Cai; Mohammad H. Rahbar; Stephanie Parker; Ritvij Bowry; James C. Grotta
Stroke | 2016
Amanda Jagolino; Shima Bozorgui; Jignesh Patel; Malcolm Irani; Christy Ankrom; Tc Cossey; Anjail Sharrief; Farhaan Vahidy; Sean I. Savitz; Tzu Ching Wu
Neurology | 2016
Amanda Jagolino; Shima Bozorgui; Tiffany Cossey; Christy Ankrom; Jignesh Patel; Malcolm Irani; Farhaan Vahidy; Sean I. Savitz; Tzu-Ching Wu
Neurology | 2016
Amanda Jagolino; Chunyan Cai; Mohammad H. Rahbar; Ritvij Bowry; Stephanie Parker; James C. Grotta
Neurology | 2016
Tiffany Cossey; Shima Bozorgui; Amanda Jagolino; Farhaan Vahidy; Tzu Ching Wu; Sean I. Savitz
Neurology | 2016
Amanda Jagolino; Shima Bozorgui; Jignesh Patel; Malcolm Irani; Christy Ankrom; Tiffany Cossey; Anjail Sharrief; Farhaan Vahidy; Sean I. Savitz; Tzu-Ching Wu
Stroke | 2015
Kasey Gildersleeve; Amanda Jagolino; Hari Indupuru; Chunyan Cai; Mohammad H. Rahbar; Amrou Sarraj; Sean I. Savitz; Tsu-Ching Wu